ATG7 and acute myeloid leukemia: In acute myeloid leukemia (AML), TP53INP2 is upregulated by FTO-mediated modification of m6A, which enhances autophagy activity by promoting the interaction of LC3 and ATG7, ultimately promoting leukemia cell survival [135].